

HCIT & Life Sciences

The intersection of trends in HCIT and Life Sciences technology is a core thesis that we continue to applaud. These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.

Transactions

AGC Partners Advises The White Stone Group on its Sale to MEA | NEA

AGC did a great job bringing us companies we weren't aware of previously. This resulted in us being acquired by a company which was a great strategic fit. The entire AGC team served as a valued advisor and helped make this transaction a success.

Jeff Peters, President & CEO of The White Stone Group

AGC Partners acted as sole financial advisor to The White Stone Group in September, 2015

AGC Partners Advises Quantia on its Sale to Physicians Interactive

AGC Partners Advises Greenphire on its Sale to The Riverside Company

Deal Team

Hugh Hoffman

Partner

Michael Howe

Partner

John Tinkham

Partner

Related Insights

© In the U.S., America’s Growth Capital, LLC dba AGC Partners, member FINRA/SIPC. In Europe, America’s Growth Capital Europe, LLP (Appointed Representative Alternatives St. James, LLP which is authorized and regulated by the Financial Conduct Authority). America’s Growth Capital Europe, LLP is a Limited Liability Partnership incorporated in England and Wales (OC368580). Its registered address is 6th Floor, 9 Appold Street, London EC2A 2AP. The testimonials contained herein may not be representative of the experience of other customers or clients. Testimonials are no guarantee of future performance or success. Deals marked with an “*” are non-AGC deals.

HCIT & Life Sciences